Search results: Sage Journals

Free accessResearch articleFirst published 2020

Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis

T.J.S. Bekooij, H.J. Gilhuis, L. Dawson [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published March, 2025

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Vera Bril, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2026

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study

Qian Zhou, Yuzhen Ouyang, Fei Jiang [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2024

Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,double-blind,placebo-controlled,adaptive phase III MycarinG study

Ali A. Habib, Sabrina Sacconi, Giovanni Antonini [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis

Yufan Zhou, Qian Zhou, Yaoxian Yue [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2019

Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential

Antonio Junior Lepedda, Giovanni Andrea Deiana, Omar Lobina [...]

Journal of Circulating Biomarkers

Open accessResearch articleFirst published May, 2026

Longitudinal treatment patterns in myasthenia gravis: An analysis from the prospective Dutch-Belgian patient registry

Linda Remijn-Nelissen, Martijn R Tannemaat, Jan JGM Verschuuren

Journal of Neuromuscular Diseases

Free accessResearch articleFirst published August 30, 2016

Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls

Carmelo Rodolico, Daniela Parisi, Simona Portaro [...]

Journal of Neuromuscular Diseases

Open accessReview articleFirst published 2018

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies

Renato Mantegazza, Carlo Antozzi

Therapeutic Advances in Neurological Disorders

Open accessReview articleFirst published May, 2026

On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales

Amol K Bhandage, Yu-Fang Huang, Tanel Punga [...]

Journal of Neuromuscular Diseases

Free accessResearch articleFirst published 2020

Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis

T.J.S. Bekooij, H.J. Gilhuis, L. Dawson [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published March, 2025

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Vera Bril, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2026

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study

Qian Zhou, Yuzhen Ouyang, Fei Jiang [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2024

Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,double-blind,placebo-controlled,adaptive phase III MycarinG study

Ali A. Habib, Sabrina Sacconi, Giovanni Antonini [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis

Yufan Zhou, Qian Zhou, Yaoxian Yue [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2019

Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential

Antonio Junior Lepedda, Giovanni Andrea Deiana, Omar Lobina [...]

Journal of Circulating Biomarkers

Open accessResearch articleFirst published May, 2026

Longitudinal treatment patterns in myasthenia gravis: An analysis from the prospective Dutch-Belgian patient registry

Linda Remijn-Nelissen, Martijn R Tannemaat, Jan JGM Verschuuren

Journal of Neuromuscular Diseases

Free accessResearch articleFirst published August 30, 2016

Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls

Carmelo Rodolico, Daniela Parisi, Simona Portaro [...]

Journal of Neuromuscular Diseases

Open accessReview articleFirst published 2018

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies

Renato Mantegazza, Carlo Antozzi

Therapeutic Advances in Neurological Disorders

Open accessReview articleFirst published May, 2026

On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales

Amol K Bhandage, Yu-Fang Huang, Tanel Punga [...]

Journal of Neuromuscular Diseases